1. Home
  2. WWR vs BSEM Comparison

WWR vs BSEM Comparison

Compare WWR & BSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WWR

Westwater Resources Inc.

HOLD

Current Price

$0.52

Market Cap

68.8M

ML Signal

HOLD

Logo BioStem Technologies Inc. Common Stock

BSEM

BioStem Technologies Inc. Common Stock

N/A

Current Price

$4.06

Market Cap

76.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WWR
BSEM
Founded
1977
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.8M
76.9M
IPO Year
2006
2026

Fundamental Metrics

Financial Performance
Metric
WWR
BSEM
Price
$0.52
$4.06
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $1.92
N/A
AVG Volume (30 Days)
★ 686.5K
144.6K
Earning Date
05-13-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$2.25
52 Week High
$3.75
$5.44

Technical Indicators

Market Signals
Indicator
WWR
BSEM
Relative Strength Index (RSI) 43.84 49.99
Support Level $0.48 $3.69
Resistance Level $0.62 $4.65
Average True Range (ATR) 0.03 0.46
MACD -0.01 -0.02
Stochastic Oscillator 19.40 17.56

Price Performance

Historical Comparison
WWR
BSEM

About WWR Westwater Resources Inc.

Westwater Resources Inc is an energy technology company focused on developing battery-grade natural graphite materials through a vertically integrated, mine-to-market strategy anchored by its two primary projects in Coosa County, Alabama: the Kellyton Graphite Plant and the Coosa Graphite Deposit. Westwater also holds mineral rights to explore and mine the Coosa Graphite Deposit, which Westwater anticipates will eventually provide natural graphite flake concentrate as feedstock to the Kellyton Graphite Plant.

About BSEM BioStem Technologies Inc. Common Stock

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

Share on Social Networks: